Expecto Health collaborates with & Ubuntu Research to fast-track global biotech breakthroughs
New Delhi: Expecto Health Science, a Singapore-based clinical research organisation, has formed a synergistic partnership with Ubuntu Research Inc. (USA), a knowledge-driven research institute and biotech incubator.
The collaboration combines Ubuntu Research’s strong expertise in translational science, biotech innovation and early-stage asset acceleration with Expecto Health Science’s robust capabilities in global clinical trial execution, regulatory strategy and operational excellence.
By combining their strengths, the companies aim to accelerate the journey from bench to bedside for promising therapies; streamline early clinical development through data-driven and patient-centric approaches; and enable biotech innovators worldwide to bring transformative medicines to those who need them most.
Dr. Pramod Kashid CEO, of Expecto Health Science said, “At Expecto Health Science, we have built our reputation on delivering high-quality, flexible, and cost-effective clinical trial solutions across the Asia-Pacific region. Our collaboration with Ubuntu Research Inc strengthens our ability to support Asian biopharma companies in navigating the complex US regulatory environment from IND submissions to NDA approvals. By combining Expecto Health Science’s operational excellence with Ubuntu Research Inc’s strategic regulatory expertise, we are enabling a truly global development pathway for our clients, while keeping patient centricity and scientific integrity at the core.”
Vishal Mehta, CEO, Founder, Ubuntu Research Inc commented, “This is the power of synergistic partnerships- where complementary strengths create outsized value for biotech founders and funders alike”. By bridging geographies and uniting capabilities, we aim to transform bold ideas into breakthrough therapies- faster, smarter, and with patient needs at the center.”
The post Expecto Health collaborates with & Ubuntu Research to fast-track global biotech breakthroughs appeared first on BioVoiceNews.
News